Active repetitive transcranial magnetic stimulation (rTMS)
Active repetitive transcranial magnetic stimulation (rTMS) is a medical device with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
GAIN Symptoms: Post-traumatic Headache
Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
OUD (Opioid Use Disorder) Target Trial
Cortical Excitability and Role of Non Invasive Brain Stimulation in ADHD and AUTISM
Dual-Task Improvement in Parkinson's Via rTMS
Clinical Trials (11)
GAIN Symptoms: Post-traumatic Headache
Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
OUD (Opioid Use Disorder) Target Trial
Cortical Excitability and Role of Non Invasive Brain Stimulation in ADHD and AUTISM
Dual-Task Improvement in Parkinson's Via rTMS
Pain and Perceptual Distortion of Face
Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder
Neurophysiology of Fibromyalgia
Treatment and Recovery Monitoring of Post TBI Symptoms
Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients
Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11